Current use of venlafaxine not associated with excess risk of sudden cardiac death or near death compared with fluoxetine, citalopram or dosulepin.
Mansfield
Joanna K
JK
University Health Network, University of Toronto, Ontario, Canada.
Kennedy
Sidney H
SH